lutein has been researched along with Cardiac Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Gao, J; Huo, S; Liu, Y; Min, D; Ren, P; Tong, L; Wu, J; Yang, G | 1 |
| Chang, W; Chen, Y; Huang, S; Ke, J; Wang, L; Wang, Q; Zhou, Z | 1 |
2 other study(ies) available for lutein and Cardiac Hypertrophy
| Article | Year |
|---|---|
Lutein suppresses ferroptosis of cardiac microvascular endothelial cells via positive regulation of IRF in cardiac hypertrophy.
Topics: Cardiomegaly; Cells, Cultured; Endothelial Cells; Ferroptosis; Heart Failure; Humans; Interferon Regulatory Factors; Lutein | 2023 |
Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Interleukin-11; Lutein; Mice; Mice, Inbred C57BL; Myocardium; Rats; Transcription Factor AP-1; Ventricular Remodeling | 2021 |